CGS Insider Trading (Cogstate)
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$84,000.00
Insider Selling (Last 12 Months): A$442,750.00
Cogstate Share Price & Price History
Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET
27 U.S. Cities Where Stocks Yield 26% a Year
From Investing Daily | Ad
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!
When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.
Cogstate Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 12/3/2021 | Bradley O'Connor | Insider | Issued | 1,000,000 | A$2.33 | A$2,330,000.00 | | |
| 10/12/2021 | Richard van den Broek | Insider | Buy | 100,000 | A$0.84 | A$84,000.00 | | |
| 9/14/2021 | Martyn Myer | Insider | Sell | 250,000 | A$1.77 | A$442,750.00 | | |
| 3/23/2021 | Bradley O'Connor | Insider | Exercise | 750,000 | A$0.84 | A$630,000.00 | | |
| 3/9/2021 | Bradley O'Connor | Insider | Sell | 2,250,000 | A$0.90 | A$2,025,000.00 | | |
| 11/2/2020 | Bradley O'Connor | Insider | Issued | 1,250,000 | A$1.11 | A$1,387,500.00 | | |
| 3/13/2020 | Bradley O'Connor | Insider | Buy | 1,100,000 | A$0.21 | A$231,000.00 | | |
27 U.S. Cities Where Stocks Yield 26% a Year
From Investing Daily | Ad
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!
When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.
SEC Filings (Institutional Ownership Changes) for Cogstate (ASX:CGS)
Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain health applications in Australia and internationally. The company's services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist in the early detection of cognitive decline. As of June 30, 2021, it had participated in approximately 1,800 academic research studies in approximately 200 indications. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.
Read More on Cogstate
Today's Range
Now: N/A
50 Day Range
MA: N/A
52 Week Range
Now: N/A
Volume
2,002 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Who are the company insiders with the largest holdings of Cogstate?
